SDGR Quote, Financials, Valuation and Earnings

MedLink International, Inc. has a net margin of 37.27% compared to Schrödinger, Inc.'s net margin of --. Schrödinger, Inc.'s return on equity of -28.32% beat MedLink International, Inc.'s return on equity of --.

Schrödinger, Inc. has a consensus price target of $23.67, signalling upside risk potential of 85.48%. On the other hand MedLink International, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Schrödinger, Inc. has higher upside potential than MedLink International, Inc., analysts believe Schrödinger, Inc. is more attractive than MedLink International, Inc..

Schrödinger, Inc. has a beta of 1.571, which suggesting that the stock is 57.066% more volatile than S&P 500. In comparison MedLink International, Inc. has a beta of -52.051, suggesting its less volatile than the S&P 500 by 5305.101%.

Schrödinger, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. MedLink International, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Schrödinger, Inc. pays -- of its earnings as a dividend. MedLink International, Inc. pays out -- of its earnings as a dividend.

Schrödinger, Inc. quarterly revenues are $87.2M, which are larger than MedLink International, Inc. quarterly revenues of --. Schrödinger, Inc.'s net income of $32.5M is higher than MedLink International, Inc.'s net income of --. Notably, Schrödinger, Inc.'s price-to-earnings ratio is -- while MedLink International, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Schrödinger, Inc. is 3.66x versus 0.00x for MedLink International, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Simulations Plus, Inc. has a net margin of 37.27% compared to Schrödinger, Inc.'s net margin of 3.67%. Schrödinger, Inc.'s return on equity of -28.32% beat Simulations Plus, Inc.'s return on equity of -42.84%.

Schrödinger, Inc. has a consensus price target of $23.67, signalling upside risk potential of 85.48%. On the other hand Simulations Plus, Inc. has an analysts' consensus of $24.67 which suggests that it could grow by 104.03%. Given that Simulations Plus, Inc. has higher upside potential than Schrödinger, Inc., analysts believe Simulations Plus, Inc. is more attractive than Schrödinger, Inc..

Schrödinger, Inc. has a beta of 1.571, which suggesting that the stock is 57.066% more volatile than S&P 500. In comparison Simulations Plus, Inc. has a beta of 1.120, suggesting its more volatile than the S&P 500 by 11.977%.

Schrödinger, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Simulations Plus, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.06 per share. Schrödinger, Inc. pays -- of its earnings as a dividend. Simulations Plus, Inc. pays out -48.18% of its earnings as a dividend.

Schrödinger, Inc. quarterly revenues are $87.2M, which are larger than Simulations Plus, Inc. quarterly revenues of $18.4M. Schrödinger, Inc.'s net income of $32.5M is higher than Simulations Plus, Inc.'s net income of $676K. Notably, Schrödinger, Inc.'s price-to-earnings ratio is -- while Simulations Plus, Inc.'s PE ratio is 49.91x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Schrödinger, Inc. is 3.66x versus 3.10x for Simulations Plus, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Veeva Systems, Inc. has a net margin of 37.27% compared to Schrödinger, Inc.'s net margin of 29.12%. Schrödinger, Inc.'s return on equity of -28.32% beat Veeva Systems, Inc.'s return on equity of 13.78%.

Schrödinger, Inc. has a consensus price target of $23.67, signalling upside risk potential of 85.48%. On the other hand Veeva Systems, Inc. has an analysts' consensus of $302.60 which suggests that it could grow by 65.48%. Given that Schrödinger, Inc. has higher upside potential than Veeva Systems, Inc., analysts believe Schrödinger, Inc. is more attractive than Veeva Systems, Inc..

Schrödinger, Inc. has a beta of 1.571, which suggesting that the stock is 57.066% more volatile than S&P 500. In comparison Veeva Systems, Inc. has a beta of 1.076, suggesting its more volatile than the S&P 500 by 7.579%.

Schrödinger, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Veeva Systems, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Schrödinger, Inc. pays -- of its earnings as a dividend. Veeva Systems, Inc. pays out -- of its earnings as a dividend.

Schrödinger, Inc. quarterly revenues are $87.2M, which are smaller than Veeva Systems, Inc. quarterly revenues of $811.2M. Schrödinger, Inc.'s net income of $32.5M is lower than Veeva Systems, Inc.'s net income of $236.2M. Notably, Schrödinger, Inc.'s price-to-earnings ratio is -- while Veeva Systems, Inc.'s PE ratio is 35.53x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Schrödinger, Inc. is 3.66x versus 9.92x for Veeva Systems, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Nano Mobile Healthcare has a net margin of 37.27% compared to Schrödinger, Inc.'s net margin of --. Schrödinger, Inc.'s return on equity of -28.32% beat Nano Mobile Healthcare's return on equity of --.

Schrödinger, Inc. has a consensus price target of $23.67, signalling upside risk potential of 85.48%. On the other hand Nano Mobile Healthcare has an analysts' consensus of -- which suggests that it could fall by --. Given that Schrödinger, Inc. has higher upside potential than Nano Mobile Healthcare, analysts believe Schrödinger, Inc. is more attractive than Nano Mobile Healthcare.

Schrödinger, Inc. has a beta of 1.571, which suggesting that the stock is 57.066% more volatile than S&P 500. In comparison Nano Mobile Healthcare has a beta of -1.161, suggesting its less volatile than the S&P 500 by 216.13%.

Schrödinger, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nano Mobile Healthcare offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Schrödinger, Inc. pays -- of its earnings as a dividend. Nano Mobile Healthcare pays out -- of its earnings as a dividend.

Schrödinger, Inc. quarterly revenues are $87.2M, which are larger than Nano Mobile Healthcare quarterly revenues of --. Schrödinger, Inc.'s net income of $32.5M is higher than Nano Mobile Healthcare's net income of --. Notably, Schrödinger, Inc.'s price-to-earnings ratio is -- while Nano Mobile Healthcare's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Schrödinger, Inc. is 3.66x versus -- for Nano Mobile Healthcare. Usually stocks with elevated PS ratios are considered overvalued.